Research Summary
Oligonucleotide therapeutics are a class of therapeutic agents that utilize short DNA or RNA molecules, typically consisting of 20-50 nucleotides, to modulate gene expression or target specific disease-causing molecules in the body. These therapeutics can be designed to selectively bind to messenger RNA (mRNA), microRNA (miRNA), or other nucleic acid targets, interfering with their function or promoting specific biological processes. Oligonucleotide therapeutics can act by various mechanisms, including downregulating gene expression through mRNA degradation or blocking translation, correcting abnormal splicing of mRNA, or selectively inhibiting specific proteins or enzymes involved in disease processes. This versatile class of therapeutics has shown promise in treating a wide range of diseases, including genetic disorders, viral infections, neurological disorders, and cancer. Oligonucleotide therapeutics are typically delivered to target tissues or cells through various delivery systems, such as lipid nanoparticles or conjugates. Their development is an active area of research and clinical investigation, with several oligonucleotide-based drugs already approved for clinical use and many more in development.
According to DIResearch's in-depth investigation and research, the global Oligonucleotide Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Bausch & Lomb, Jazz Pharmaceuticals, Alnylam Pharmaceuticals, Akcea Therapeutics, Dynavax Technologies, Kastle therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Oligonucleotide Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oligonucleotide Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oligonucleotide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oligonucleotide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oligonucleotide Therapeutics Include:
Biogen
Sarepta Therapeutics
Bausch & Lomb
Jazz Pharmaceuticals
Alnylam Pharmaceuticals
Akcea Therapeutics
Dynavax Technologies
Kastle therapeutics
Oligonucleotide Therapeutics Product Segment Include:
Antisense Oligonucleotide
Aptamer
Others
Oligonucleotide Therapeutics Product Application Include:
Neuromuscular Diseases
ATTR
Hepatic VOD
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oligonucleotide Therapeutics Industry PESTEL Analysis
Chapter 3: Global Oligonucleotide Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Oligonucleotide Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Oligonucleotide Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oligonucleotide Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Oligonucleotide Therapeutics Market Overview 1.1 Product Definition and Statistical Scope 1.2 Oligonucleotide Therapeutics Product by Type 1.2.1 Global Oligonucleotide Therapeutics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Antisense Oligonucleotide 1.2.3 Aptamer 1.2.4 Others 1.3 Oligonucleotide Therapeutics Product by Application 1.3.1 Global Oligonucleotide Therapeutics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Neuromuscular Diseases 1.3.3 ATTR 1.3.4 Hepatic VOD 1.3.5 Others 1.4 Global Oligonucleotide Therapeutics Market Revenue Analysis (2019-2030) 1.5 Oligonucleotide Therapeutics Market Development Status and Trends 1.5.1 Oligonucleotide Therapeutics Industry Development Status Analysis 1.5.2 Oligonucleotide Therapeutics Industry Development Trends Analysis 2 Oligonucleotide Therapeutics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Oligonucleotide Therapeutics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Oligonucleotide Therapeutics Market Analysis by Regions 4.1 Oligonucleotide Therapeutics Overall Market: 2023 VS 2024 VS 2030 4.2 Global Oligonucleotide Therapeutics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Oligonucleotide Therapeutics Revenue and Market Share by Region (2019-2024) 4.2.2 Global Oligonucleotide Therapeutics Revenue Forecast by Region (2025-2030) 5 Global Oligonucleotide Therapeutics Market Size by Type and Application 5.1 Global Oligonucleotide Therapeutics Market Size by Type 5.2 Global Oligonucleotide Therapeutics Market Size by Application 6 North America 6.1 North America Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Oligonucleotide Therapeutics Market Size by Type 6.4 North America Oligonucleotide Therapeutics Market Size by Application 6.5 North America Oligonucleotide Therapeutics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Oligonucleotide Therapeutics Market Size by Type 7.4 Europe Oligonucleotide Therapeutics Market Size by Application 7.5 Europe Oligonucleotide Therapeutics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Oligonucleotide Therapeutics Market Size by Type 8.4 China Oligonucleotide Therapeutics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Type 9.4 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Application 9.5 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Oligonucleotide Therapeutics Market Size by Type 10.4 Latin America Oligonucleotide Therapeutics Market Size by Application 10.5 Latin America Oligonucleotide Therapeutics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Oligonucleotide Therapeutics Market Size by Type 11.4 Middle East & Africa Oligonucleotide Therapeutics Market Size by Application 11.5 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Oligonucleotide Therapeutics Market Revenue by Key Manufacturers (2020-2024) 12.2 Oligonucleotide Therapeutics Competitive Landscape Analysis and Market Dynamic 12.2.1 Oligonucleotide Therapeutics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Biogen 13.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Biogen Oligonucleotide Therapeutics Product Portfolio 13.1.3 Biogen Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Sarepta Therapeutics 13.2.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Sarepta Therapeutics Oligonucleotide Therapeutics Product Portfolio 13.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Bausch & Lomb 13.3.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Bausch & Lomb Oligonucleotide Therapeutics Product Portfolio 13.3.3 Bausch & Lomb Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Jazz Pharmaceuticals 13.4.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio 13.4.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Alnylam Pharmaceuticals 13.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio 13.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Akcea Therapeutics 13.6.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Akcea Therapeutics Oligonucleotide Therapeutics Product Portfolio 13.6.3 Akcea Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Dynavax Technologies 13.7.1 Dynavax Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Dynavax Technologies Oligonucleotide Therapeutics Product Portfolio 13.7.3 Dynavax Technologies Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Kastle therapeutics 13.8.1 Kastle therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Kastle therapeutics Oligonucleotide Therapeutics Product Portfolio 13.8.3 Kastle therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Oligonucleotide Therapeutics Industry Chain Analysis 14.2 Oligonucleotide Therapeutics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Oligonucleotide Therapeutics Typical Downstream Customers 14.4 Oligonucleotide Therapeutics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support